SNAIL SOLU TION WRINKLE UP SPOT

Manufacturer
NATURE REPUBLIC CO., LTD. | Cosmax, Inc
Effective date
2017-01-19
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:20:37

Label at a glance#

ProductSNAIL SOLU TION WRINKLE UP SPOT
Active ingredientNIACINAMIDE, ADENOSINE
Label structure8 sections

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active ingredients: NIACINAMIDE (2.00%), ADENOSINE (0.04%)

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive ingredients: Snail Secretion Filtrate, HDI/Trimethylol Hexyllactone Crosspolymer, Dimethicone/Vinyl Dimethicone Crosspolymer, Water, Butyrospermum Parkii (Shea) Butter, Butylene Glycol, Trehalose, Cetearyl Alcohol, Chondrus Crispus Extract, Saccharum Officinarum (Sugarcane) Extract, C12-14 Pareth-7, 1,2-Hexanediol, Beeswax, Pentylene Glycol, Glycerin, Dipropylene Glycol, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Dimethicone, Silica, Isohexadecane, Caprylyl Glycol, Fragrance(Parfum), Polysorbate 80, Phenoxyethanol, Sodium Lauroyl Lactylate, Sorbitan Stearate, Trideceth-12, Sorbitan Oleate, Disodium EDTA, Tocopheryl Acetate, Algae Extract (Retired), Cassia Angustifolia Seed Polysaccharide, Ceramide NP, Madecassoside, Vanilla Planifolia Fruit Extract, Caprylhydroxamic Acid

PURPOSE

OTC - PURPOSE SECTION

Purpose: Skin Moisturizing & Anti-Wrinkle Improvement

WARNINGS

WARNINGS SECTION

Warnings: For external use only. Avoid contact with eyes and mouth. Discontinue use if signs of irritation or rashes appear. Keep out of reach of children. Replace the cap after use.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

INDICATIONS & USAGE

INDICATIONS & USAGE SECTION

Indications & Usage: Moisturizes the skin around the eye area with anti-aging benefit.

DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Dosage & Administration: Apply an appropriate amount (the size of one rice grain) around the eye area in an upward motion. Tip 1. Before and after applying the product, avoid using oily products. 2. If used with eye cream, apply only once eye cream is fully absorbed. 3. To avoid product clumping, gently pat skin for maximum absorption.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-138806173434930GTIN-13: 8806173434930
EAN-13: 8806173434930
GTIN storage (14 digits): 08806173434930
snail solution wrinkle up spot carton.jpg

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
51346-431-022021-06-22C16284748780-1ba0f9c33-36b4-a910-e053-dadaa90a0b85c3b2eaec-fa2e-485f-893a-4a0d1e489a08
51346-431-022021-01-29C16284748780-1ba0f9c33-36b4-a910-e053-dadaa90a0b85c3b2eaec-fa2e-485f-893a-4a0d1e489a08

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
51346-43151346-431-01, 51346-431-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
NameUNIIKind
NIACINAMIDE25X51I8RD4ACTIB
ADENOSINEK72T3FS567ACTIB
Water059QF0KO0RIACT
SHEA BUTTERK49155WL9YIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ad9c8075-ff5c-4c01-8d33-2334a564d88fc3b2eaec-fa2e-485f-893a-4a0d1e489a082021-06-22WarningsExact identifier
spl set id: c3b2eaec-fa2e-485f-893a-4a0d1e489a08

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.